Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

2.91
Delayed Data
As of Feb 05
 -0.11 / -3.64%
Today’s Change
2.78
Today|||52-Week Range
8.59
-31.04%
Year-to-Date

Today’s Trading

Previous close3.02
Today’s open3.00
Day’s range2.89 - 3.05
Volume2,600,963
Average volume (3 months)2,770,763
Market cap$415.0M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-922.45%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+23.36%
P/E ratio26.3
Price/Sales19.68
Price/Book9.70

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.01-1.34%
COCPCocrystal Pharma Inc-0.03-4.44%
OMEROmeros Corp-0.50-4.31%
SGYPSynergy Pharmaceutic...-0.24-6.28%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMay 2, 2016
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$51.9M
Annual profit (last year)$9.4M
Net profit margin18.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers